📱 Now on iPhone — live scores, valuations & alerts on the go
Create an account for unlimited access
HARVARD BIOSCIENCE INC (HBIO)
Healthcare
Model Divergence
weak
$8.02
Updated: 2026-08-31
39
TradeApes Score
Financial Strength
41
Weak
Operating Trend
34
Weak
Relative Value
35
Overvalued
Capital Allocation
36
Weak
Risk Management
57
Mixed
Market Implies
~50% growth
Sector Rank
#8038
The market price implies growth our normalized base can't support, so we don't publish a single fair-value figure for HBIO.
Key Findings
+
accruals ratio
−
ROIC − WACC (value creation)
Industry Related Stocks
Get HBIO and 3,000+ stocks in your pocket
Health scores, fair-value estimates, and full company analysis — free on iPhone.
Download iPhone App
TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor.
The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.
Sign up for our Weekly Sector Leaders Newsletter
11 sector-leading stocks delivered to your inbox every Sunday. Free.
No spam. Unsubscribe anytime.